PAR paradigm biopharmaceuticals limited..

The Future, page-7

  1. 1,625 Posts.
    lightbulb Created with Sketch. 677

    I’m pretty interested in the potential for near term revenue (with Provisional Approval in Australia not dependent on P3 results).

    From the recent corporate update.....
    https://hotcopper.com.au/data/attachments/1544/1544441-f763bfd1648ca34145e957fedf10b3e9.jpg
    My understanding is that approval could be granted in about 12 months from first filings. From this link....
    https://www.tga.gov.au/provisional-approval-implementation-arrangements

    Hence I presume potential near term revenue around the middle of next year which would be before a P3 readout and the risk associated with that...
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
43.0¢
Change
-0.035(7.53%)
Mkt cap ! $170.8M
Open High Low Value Volume
47.0¢ 47.5¢ 42.0¢ $676.1K 1.519M

Buyers (Bids)

No. Vol. Price($)
2 16161 43.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 19584 1
View Market Depth
Last trade - 16.10pm 07/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.